pre-ipo
Stage
2015
Founded
1
Investors
About
Minghui Pharmaceutical is a clinical-stage biopharmaceutical company focused on developing therapeutic drug candidates and preparing for global commercialization, having recently completed a $131 million pre-IPO financing round to advance its late-stage programs.
Explore Minghui Pharmaceutical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.